The following Life Sciences practice note provides comprehensive and up to date legal information covering:
This Practice Note is intended to be used to track key developments and guidance related to Brexit in the life sciences sector.
Negotiations on the EU-UK relationship from 1 January 2021 and implementation of the Withdrawal Agreement
UK government policy papers, documents and consultations
UK Parliament inquiries, briefing papers and updates
Industry and independent reports
Relocation of the EMA
For more information and considerations on the key issues that are likely to affect the life sciences sector as a result of Brexit, see Practice Note: Brexit—implications of the Withdrawal Agreement for the life sciences sector.
For an overview and more detailed discussion of the regulation of medicinal products, clinical trials and medical devices after the end of the transition period, see Practice Notes:
What does IP completion day mean for medicinal products?
What does IP completion day mean for clinical trials?
What does IP completion day mean for medical devices?
Post-Brexit transition period—the regulation of medicinal products
Post-Brexit transition period—medical devices
The Political Declaration, which set out the framework for the future EU-UK relationship, was agreed by the UK and the EU in October 2019. The Political Declaration, which is a non-binding agreement, includes the following key objectives of interest to the life sciences
**Trials are provided to all LexisPSL and LexisLibrary content, excluding Practice Compliance, Practice Management and Risk and Compliance, subscription packages are tailored to your specific needs. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Dividends involve a distribution of cash or a distribution of non-cash assets (known as a distribution in kind or a distribution in specie).A scrip dividend (in a tax context, sometimes referred to as a stock dividend) allows a shareholder to receive new shares in a company as an alternative to a
This Practice Note covers the legal framework and regulatory guidance to be considered in determining whether an arrangement constitutes a contract of insurance and the possible consequences of carrying on activities relating to a contract of insurance without the requisite regulatory permissionsThe
Coronavirus (COVID-19): During the current pandemic, legislation and changes to practice and procedure in the courts and tribunals have been introduced, which affect the following:•proceedings for possession•forfeiture of business leases on the grounds of non-payment of rent•a landlord's right to
STOP PRESS: The Corporate Insolvency and Governance Act 2020 contains provisions which, on a temporary basis (presently until 31 December 2020) impose significant limitations on the ability for a creditor to seek a winding-up order against a company. For further reading, see Practice Note: Corporate
0330 161 1234
To view our latest legal guidance content,sign-in to Lexis®PSL or register for a free trial.